Elevance Health Inc Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: October 21, 2026 results vs estimates
Elevance Health Inc Forecast
Elevance Health Inc short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 25.7% a year, a typical one-standard-deviation range is 406.72–437.32 over a week, 390.67–453.37 over a month and 313.43–530.61 over a year. (Signals as of 1 Nov 2026.)
Elevance Health Inc Price Chart
Elevance Health Inc Factors
YoY +36.1%
YoY +22.0%
YoY +24.4%
YoY −0.4%
YoY −14.8%
YoY +36.8%
YoY −26.5%
YoY −22.2%
YoY +26.4%
YoY −130.3%
YoY −134.2%
YoY +13.6%
YoY +13.6%
YoY +5.5%
YoY −5.7%
YoY +40.0%
YoY +7.8%
Elevance Health Inc fundamentals: income statement, balance sheet & cash flow
Elevance Health Inc reported revenue of $199.13bn and net income of $5.66bn in FY2025, the year ended 31 December 2025 — revenue up 12.6% and net income down 5.3% on the prior year. Free cash flow was $3.17bn. These figures are as reported in the filings, not restated: 28 fiscal years and 107 quarters of history, back to December 1998. 103 FINRA short-interest settlements are published alongside them, back to June 2022.
| USD billions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 199.13 | 176.81 | 171.34 | 156.60 | 138.64 |
| Cost of revenue | 148.22 | 127.57 | 124.33 | 116.64 | 102.65 |
| Gross profit | 50.90 | 49.24 | 47.01 | 39.95 | 35.99 |
| Selling, general & admin. | — | — | — | 7.45 | 0.01 |
| Operating income | 8.11 | 8.89 | 8.75 | 8.45 | 8.95 |
| EBITDA | 9.66 | 10.48 | 10.49 | 10.13 | 10.03 |
| Interest expense | 1.40 | 1.19 | 1.03 | 0.85 | 0.80 |
| Pre-tax income | 6.71 | 7.90 | 7.72 | 7.60 | 7.93 |
| Income tax | 1.05 | 1.93 | 1.72 | 1.71 | 1.83 |
| Net income | 5.66 | 5.98 | 5.99 | 5.89 | 6.10 |
Download Elevance Health Inc fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.ELV.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Elevance Health Inc
Explore MacroFinance macro & markets research and analysis.
Elevance Health Inc Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Elevance Health Inc; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Elevance Health Inc’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Elevance Health Inc (United States)
Elevance Health Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Elevance Health Inc
Frequently asked questions
What is Elevance Health Inc?
What is the latest Elevance Health Inc price?
Is Elevance Health Inc in an uptrend?
How volatile is Elevance Health Inc?
What factors affect Elevance Health Inc?
Which trading strategies trade Elevance Health Inc?
How are Elevance Health Inc returns analysed?
Where can I download free Elevance Health Inc historical data?
Free Elevance Health Inc historical data (last 10 years)
Browse or instantly download the last 10 years of Elevance Health Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ELV.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 394.48 |
| 2026-11-19 | 390.16 |
| 2026-11-18 | 400.84 |
| 2026-11-17 | 433.93 |
| 2026-11-16 | 446.28 |
| 2026-11-13 | 429.69 |
| 2026-11-12 | 429.9 |
| 2026-11-11 | 429.48 |
| 2026-11-10 | 429.65 |
| 2026-11-09 | 418.25 |
About this stock
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.